XBI Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | US Equities - Industry Sector | Expense | 0.35% | Return% 1Y | 41.76% | Total Holdings | 167 | Perf Week | 4.06% | Volume | 10,928,984 |
| Asset Type | Equities (Stocks) | AUM | $10.82B | Return% 3Y | 34.28% | NAV | $157.46 | Perf Month | 0.07% | Avg Volume | 8.85M |
| ETF Type | US Equities | Dividend TTM | $0.54 (0.35%) | Return% 5Y | 5.16% | 52W High | -7.12% | Perf Quarter | 7.33% | Rel Volume | 1.24 |
| Active/Passive | Passive | Div Gr. 3/5Y | - 9.6% | Return% 10Y | 10.31% | 52W Low | 48.44% | Perf Half Y | 20.15% | Prev Close | $157.51 |
| IPO | 2006/2/6 | Flows% 1M | 2.76% | Return% SI | 11.83% | RSI (14) | 57.32 | Perf YTD | 29.41% | Price | $157.79 |
| Beta | 0.87 | Flows% 3M | 5.74% | Flows% YTD | 7.85% | Flows% 1Y | 13.69% | Perf Year | 42.2% | Volatility(W/M) | 2.6% 2.9% |
| SMA20 | 4.17% | SMA50 | 0.66% | SMA200 | 11.52% | ATR | 4.35 | ||||
SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
The top 10 make up 18% of the fund
Spread evenly across many holdings.
APGE Apogee Therapeutics Inc 1.49% 3 
TWST Twist Bioscience Corp 1.41% 4 
MRNA Moderna Inc 1.41% 5 
ORKA Oruka Therapeutics Inc 1.38% 6 
KYMR Kymera Therapeutics Inc 1.36% 7 
VKTX Viking Therapeutics Inc 1.30% 8 
PRAX Praxis Precision Medicines Inc 1.29% 9 
ERAS Erasca Inc 1.27% 10 
RYTM Rhythm Pharmaceuticals Inc 1.20% Largest sectors first.
Over the past 1 year, on the higher side
7% below its 1-year high.
Traded about as much as usual. That is 124% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +26.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
The price swings a lot
At its worst (February 2021) it fell 64% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 0.35% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 13.7% of assets came in.
Tap to view numbers
LABU Direxion Daily S&P Biotech Bull 3X ETF 669M 
MRNY YieldMax MRNA Option Income Strategy ETF 238M 
BIB ProShares Ultra Nasdaq Biotechnology 2X Shares 102M 
LABD-1× Direxion Daily S&P Biotech Bear 3X ETF 58M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
XLV State Street Health Care Select Sector SPDR ETF 0.08% 
VHT Vanguard Health Care ETF 0.09% 
IYH iShares U.S. Healthcare ETF 0.37% 
FHLC Fidelity MSCI Health Care Index ETF 0.08% 
IHI iShares U.S. Medical Devices ETF 0.37% 
SCHH Schwab U.S. REIT ETF 0.07% 
XLK State Street Technology Select Sector SPDR ETF 0.08% 
XLF State Street Financial Select Sector SPDR ETF 0.08% 
FAQ
How many holdings does XBI have?
XBI holds a total of 167 securities, with an AUM of approximately $10.8B.
Does XBI pay dividends (distributions)?
XBI's distribution yield is approximately 0.35%.
What is the 52-week high and low for XBI?
XBI has recorded a 52-week high of $169.89 and a low of $106.30.
